Published in Stat Med on August 30, 2001
Natural history of pain following herpes zoster. Pain (2006) 1.66
Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment. Korean J Pain (2015) 0.96
Improved survival modeling in cancer research using a reduced piecewise exponential approach. Stat Med (2013) 0.91
Postherpetic neuralgia in the elderly. Int J Clin Pract (2009) 0.90
Postherpetic neuralgia: from preclinical models to the clinic. Neurotherapeutics (2009) 0.86
Post-herpetic neuralgia. Int J Gen Med (2012) 0.82
The PINE study: rationale and design of a randomised comparison of epidural injection of local anaesthetics and steroids versus care-as-usual to prevent postherpetic neuralgia in the elderly [ISRCTN32866390]. BMC Anesthesiol (2004) 0.81
The use of narrow band ultraviolet light B in the prevention and treatment of postherpetic neuralgia (a pilot study). Indian J Dermatol (2011) 0.77
Presentation and management of herpes zoster (shingles) in the geriatric population. P T (2013) 0.75
Prevention of post-herpetic neuralgia using transcutaneous electrical nerve stimulation. Wien Klin Wochenschr (2014) 0.75
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med (1977) 5.02
Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med (1986) 4.37
Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med (1996) 4.28
A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol (1983) 3.80
Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus. J Virol (1987) 2.97
A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg (1978) 2.94
Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics (2001) 2.91
Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics (1980) 2.70
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery (1979) 2.65
Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med (1981) 2.56
Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis. Oncogene (2008) 2.48
Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer (1979) 2.41
Oral acyclovir in acute herpes zoster. Br Med J (Clin Res Ed) (1986) 2.39
Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA (1989) 2.38
Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor. J Clin Oncol (2000) 2.37
Derivation of mouse intestinal crypts from single progenitor cells. Nature (1985) 2.31
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics (2001) 2.30
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol (2001) 2.19
Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother (1995) 2.16
A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg (1982) 2.09
A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg (1981) 2.09
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Toxic megacolon: the knee-elbow position relieves bowel distension. Gut (1993) 1.93
A large outbreak of Q fever in the West Midlands: windborne spread into a metropolitan area? Commun Dis Public Health (1998) 1.92
Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus. J Infect Dis (1987) 1.91
Lack of effect of acyclovir on postherpetic neuralgia. BMJ (1989) 1.88
Herpes simplex encephalitis. Clinical Assessment. JAMA (1982) 1.83
Regulation and tissue-specific expression of human cytomegalovirus. Curr Top Microbiol Immunol (1990) 1.76
Changing presentation of herpes simplex virus infection in neonates. J Infect Dis (1988) 1.76
Acyclovir: a decade later. N Engl J Med (1992) 1.70
A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med (1990) 1.67
Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science (1987) 1.66
The prognostic significance of ulceration of cutaneous melanoma. Cancer (1980) 1.66
Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen. J Clin Oncol (2005) 1.63
Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br J Surg (1982) 1.62
Do adaptive changes in metabolic rate favor weight regain in weight-reduced individuals? An examination of the set-point theory. Am J Clin Nutr (2000) 1.61
Dna restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N Engl J Med (1982) 1.60
A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer (2000) 1.52
Predictors of sun exposure in adolescents in a southeastern U.S. population. J Adolesc Health (1996) 1.50
Adenovirus gene transfer causes inflammation in the brain. Neuroscience (1995) 1.50
Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis (1996) 1.50
Sociodemographic characteristics associated with medical appointment adherence among HIV-seropositive patients seeking treatment in a county outpatient facility. Prev Med (2001) 1.48
Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann Surg Oncol (1996) 1.48
T cell recognition of HIV synthetic peptides in a natural infection. J Immunol (1989) 1.47
A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol (1983) 1.46
Second-look laparotomy and salvage therapy: a research modality only? Gynecol Oncol (1992) 1.45
A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg (1983) 1.45
B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus. J Virol (1988) 1.42
Bayesian monitoring of phase II trials in cancer chemoprevention. J Clin Epidemiol (1999) 1.41
Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J (1996) 1.41
A power study of a sequential method of p-value adjustment for correlated continuous endpoints. J Biopharm Stat (1998) 1.40
Ciprofloxacin and Salmonella carriage. J Hosp Infect (1992) 1.39
Prognostic histopathological factors in malignant melanoma. Pathology (1985) 1.39
Effect of cloned human interferons on protein synthesis and morphogenesis of herpes simplex virus. J Virol (1985) 1.38
The use of sequential self-obtained vaginal smears for detecting changes in the vaginal flora. Sex Transm Dis (1997) 1.37
Ep-Cam levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia. J Urol (1999) 1.35
DF-2 bacteremia following cat bites. Report of two cases. Am J Med (1987) 1.32
Relationships between socioeconomic status and race-specific cervical cancer incidence in the United States, 1973-1992. J Health Care Poor Underserved (1998) 1.31
Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients. N Engl J Med (1982) 1.27
Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. British Infection Society Working Party. J Infect (1999) 1.27
Human blastomycosis after a dog bite. Ann Intern Med (1983) 1.21
Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report. Ann Intern Med (2000) 1.20
Treatment of condyloma acuminatum with three different interferons administered intralesionally. A double-blind, placebo-controlled trial. Ann Intern Med (1988) 1.19
Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma. Ann Surg (1988) 1.19
Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor. Cancer (1998) 1.18
Adenocarcinoma of the cervix. I. Clinical evaluation and pathologic features. Am J Obstet Gynecol (1981) 1.18
Ribozyme-mediated trans-splicing of a trinucleotide repeat. Nat Genet (1998) 1.16
Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapy. Pediatrics (1983) 1.16
Folate deficiency and cervical dysplasia. JAMA (1992) 1.15
Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol (1989) 1.15
Outcome for children with supratentorial primitive neuroectodermal tumors treated with surgery, radiation, and chemotherapy. Cancer (2000) 1.14
Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene. Gene Ther (2000) 1.14
Delayed primary repair of intrathoracic esophageal perforation: is it safe? J Thorac Cardiovasc Surg (1996) 1.14
Immune responses to adenoviral vectors during gene transfer in the brain. Hum Gene Ther (1997) 1.13
Vidarabine: a preliminary review of its pharmacological properties and therapeutic use. Drugs (1980) 1.12
Neck dissection with and without radiotherapy: prognostic factors, patterns of recurrence, and survival. Am J Surg (1986) 1.11
Role of T cells in inflammation caused by adenovirus vectors in the brain. Gene Ther (1996) 1.11
Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas. Clin Cancer Res (2000) 1.10
Infections caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy. J Infect Dis (1984) 1.09
Socioeconomic characteristics and melanoma incidence. Ann Epidemiol (1998) 1.09
Cannabinoids in humans. II. The influence of three methods of hydrolysis on the concentration of THC and two metabolites in urine. J Anal Toxicol (1995) 1.09
Over-the-counter antibiotics. J Antimicrob Chemother (1999) 1.07
A collaborative study of patient-initiated treatment of recurrent genital herpes with topical acyclovir or placebo. J Infect Dis (1984) 1.07
A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients. Ann Surg (1983) 1.06
Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas. Int J Cancer (2000) 1.05
Restoration of a normal reproductive lifespan after grafting of cryopreserved mouse ovaries. Hum Reprod (2000) 1.05
Effects of calcium hydroxide paste as an intracanal medicament on apical seal. J Endod (1990) 1.03
Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea. Gene Ther (1997) 1.02
Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patients. Gynecol Oncol (1991) 1.02
Evaluation of the efficacy and cost effectiveness of health education methods to increase medication adherence among adults with asthma. Am J Public Health (1990) 1.02
Cryosurgery of cervical intraepithelial neoplasia. Obstet Gynecol (1981) 1.00
Platelet surface-bound IgG in patients with immune and nonimmune thrombocytopenia. Blood (1987) 1.00